ESTRO Brachytherapy for Prostate Cancer 2018

best candidate

• histologically verified recurrent prostate cancer • neg. CT scan and skeletal scintigraphy • PSADT> 12 months • PSA < 15ng/ml • bladder capacity > 300ml, competent sphincter, no bladder neck invasion